Antibiotic-Resistant Community-Acquired Bacterial Pneumonia

Jeffery Ho; Margaret Ip

doi:10.1016/j.idc.2019.07.002

Antibiotic-Resistant Community-Acquired Bacterial Pneumonia

Infect Dis Clin North Am. 2019 Dec;33(4):1087-1103. doi: 10.1016/j.idc.2019.07.002.

Authors

Jeffery Ho¹, Margaret Ip²

Affiliations

¹ Department of Microbiology, Faculty of Medicine, Chinese University of Hong Kong, Shatin, Hong Kong.
² Department of Microbiology, Faculty of Medicine, Chinese University of Hong Kong, Shatin, Hong Kong; Department of Microbiology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong. Electronic address: margaretip@cuhk.edu.hk.

PMID: 31668192
DOI: 10.1016/j.idc.2019.07.002

Abstract

Antimicrobial resistance is a global concern, and prudent use of antibiotics is essential to preserve the current armamentarium of effective drugs. Acute respiratory tract infection is the most common reason for antibiotic prescription in adults. In particular, community-acquired pneumonia poses a significant health challenge and economic burden globally, especially in the current landscape of a dense and aging population. By updating the knowledge on the common antimicrobial-resistant pathogens in community-acquired respiratory tract infections, their prevalence, and resistance may pave the way to enhancing appropriate antibiotic use in the ambulatory and health care setting.

Keywords: Antimicrobial resistance; Community-acquired pneumonia; Haemophilus influenzae; Mycoplasma pneumoniae; Streptococcus pneumoniae.

Publication types

Review

MeSH terms

Anti-Bacterial Agents / pharmacology*
Bacteria / drug effects*
Community-Acquired Infections / microbiology*
Drug Resistance, Bacterial*
Global Health
Humans
Pneumonia, Bacterial / drug therapy*
Pneumonia, Bacterial / microbiology*

Substances

Anti-Bacterial Agents